Hostname: page-component-cb9f654ff-hn9fh Total loading time: 0 Render date: 2025-08-18T18:41:06.324Z Has data issue: false hasContentIssue false
  • English
  • Français

Hypotension associated with azithromycin infusion in children with heart failure: a case report

Part of: Infectious

Published online by Cambridge University Press:  04 March 2022

Dominic Zanaboni Open the ORCID record for Dominic Zanaboni [Opens in a new window]  and
Carolyn Vitale
Dominic Zanaboni*
Affiliation:
Division of Pediatric Cardiology, University of Michigan C.S. Mott Children’s Hospital, Ann Arbor, MI, USA
Carolyn Vitale
Affiliation:
Division of Pediatric Cardiology, University of Michigan C.S. Mott Children’s Hospital, Ann Arbor, MI, USA
*
Author for correspondence: D. Zanaboni, MD, Division of Pediatric Cardiology, University of Michigan C.S. Mott Children’s Hospital, 1540 E Hospital Dr, Ann Arbor, MI 48109, USA. Tel: 314-347-6997; Fax: 734-936-9470. E-mail: zanaboni@med.umich.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

We report two cases of acute hypotension after intravenous azithromycin administration in children with acute, decompensated heart failure. In each of our reported cases, azithromycin was being used to treat possible Mycoplasma myocarditis. In this report, we aim to describe hypotension as a potentially rare adverse reaction to intravenous azithromycin and encourage judicious use in patients with cardiac dysfunction.

Keywords

CHDmyocarditisheart failureazithromycin

Information

Type
Brief Report
Information
Cardiology in the Young , Volume 32 , Issue 11 , November 2022 , pp. 1869 - 1870
Check for updates
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

Meeting presentation: The Pediatric Cardiac Intensive Care Society: Annual International Meeting; September 20, 2021.

References

Pönkä, A. Carditis associated with mycoplasma pneumoniae infection. Acta Med Scand 1979; 206: 77–86.CrossRefGoogle ScholarPubMed
Paz, A, Potasman, I. Mycoplasma-associated carditis: case reports and review. Cardiology 2002; 97: 83–88.CrossRefGoogle ScholarPubMed
Qu, J, Gu, L, Wu, J, et al. Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia. BMC Infect Dis 2013; 13: 172.CrossRefGoogle ScholarPubMed
Martinez, MA, Ruiz, M, Zunino, E, Luchsinger, V, Avendano, LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol 2008; 57: 1491–1495.CrossRefGoogle ScholarPubMed
Ferwerda, A, Moll, HA, de Groot, R. Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures. Eur J Pediatr 2001; 160: 483–491.CrossRefGoogle ScholarPubMed
Wong, J, Munsif, M, O'Hehir, R, Hew, M, Dabscheck, E. Hypotensive episodes associated with azithromycin infusion: a potentially fatal adverse drug reaction. Respirol Case Rep 2019; 7: e00464.CrossRefGoogle ScholarPubMed
Gandhi, S, Fleet, JL, Bailey, DG, et al. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA 2013; 310: 2544–2553.CrossRefGoogle ScholarPubMed
Wright, AJ, Gomes, T, Mamdani, MM, et al. The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers. CMAJ 2011; 183: 303–307.CrossRefGoogle ScholarPubMed